EP 1204742 A2 20020515 - OLIGONUCLEOTIDES FOR INHIBITING THE EXPRESSION OF HUMAN EG5
Title (en)
OLIGONUCLEOTIDES FOR INHIBITING THE EXPRESSION OF HUMAN EG5
Title (de)
OLIGONUKLEOTIDE ZUR INHIBIERUNG DER EXPRESSION VON HUMANEM EG5
Title (fr)
OLIGONUCLEOTIDES PERMETTANT D'INHIBER L'EXPRESSION DE LA PROTEINE EG5 HUMAINE
Publication
Application
Priority
- DE 19935303 A 19990728
- EP 0007345 W 20000721
Abstract (en)
[origin: US6472521B1] The present invention relates to an oligonucleotide or a derivative thereof which has a sequence that corresponds to a particular fragment of a nucleic acid sequence which encodes human eg5 or a mutant form thereof; the invention further relates to a method of making the oligonucleotide and the use thereof.
IPC 1-7
IPC 8 full level
A61K 31/7088 (2006.01); A61K 31/7115 (2006.01); A61K 31/712 (2006.01); C12N 15/09 (2006.01); A61K 31/7125 (2006.01); A61K 48/00 (2006.01); A61P 35/00 (2006.01); A61P 35/02 (2006.01); A61P 35/04 (2006.01); A61P 43/00 (2006.01); C07H 21/00 (2006.01); C12N 15/113 (2010.01); C12N 15/12 (2006.01); A61K 38/00 (2006.01)
CPC (source: EP KR US)
A61P 35/00 (2018.01 - EP); A61P 35/02 (2018.01 - EP); A61P 35/04 (2018.01 - EP); A61P 43/00 (2018.01 - EP); C07H 21/00 (2013.01 - EP US); C12N 15/11 (2013.01 - KR); C12N 15/113 (2013.01 - EP US); A61K 38/00 (2013.01 - EP US); C07B 2200/11 (2013.01 - EP US); C12N 2310/315 (2013.01 - EP US); C12N 2310/317 (2013.01 - EP US); C12N 2310/318 (2013.01 - EP US); C12N 2310/32 (2013.01 - EP US); C12N 2310/33 (2013.01 - EP US); C12N 2310/346 (2013.01 - EP US); Y02A 50/30 (2018.01 - EP)
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
US 6472521 B1 20021029; AR 024953 A1 20021030; AU 6568200 A 20010213; BR 0013180 A 20020409; CA 2380192 A1 20010201; CN 1165617 C 20040908; CN 1367828 A 20020904; CZ 2002324 A3 20020515; DE 19935303 A1 20010208; EE 200200044 A 20030616; EP 1204742 A2 20020515; HK 1048337 A1 20030328; HK 1048337 B 20050225; HR P20020075 A2 20051031; HU P0202794 A2 20030328; HU P0202794 A3 20060328; IL 147541 A0 20020814; JP 2003505080 A 20030212; KR 20020033744 A 20020507; MX PA02000817 A 20020730; NO 20020365 D0 20020123; NO 20020365 L 20020325; NZ 516839 A 20040430; PL 353733 A1 20031201; RU 2249458 C2 20050410; SK 1162002 A3 20020604; TR 200200201 T2 20020521; WO 0107602 A2 20010201; WO 0107602 A3 20010517; YU 91901 A 20030228; ZA 200200655 B 20030923
DOCDB simple family (application)
US 62712200 A 20000727; AR P000103872 A 20000726; AU 6568200 A 20000721; BR 0013180 A 20000721; CA 2380192 A 20000721; CN 00810829 A 20000721; CZ 2002324 A 20000721; DE 19935303 A 19990728; EE P200200044 A 20000721; EP 0007345 W 20000721; EP 00953119 A 20000721; HK 03100581 A 20030123; HR P20020075 A 20020125; HU P0202794 A 20000721; IL 14754100 A 20000721; JP 2001512871 A 20000721; KR 20027001188 A 20020128; MX PA02000817 A 20000721; NO 20020365 A 20020123; NZ 51683900 A 20000721; PL 35373300 A 20000721; RU 2002105021 A 20000721; SK 1162002 A 20000721; TR 200200201 T 20000721; YU P91901 A 20000721; ZA 200200655 A 20020124